Dual Antiplatelet Therapy in Secondary Prevention of Ischemic Stroke: A Ghost from the Past or a New Frontier?

Bibliographic Details
Title: Dual Antiplatelet Therapy in Secondary Prevention of Ischemic Stroke: A Ghost from the Past or a New Frontier?
Authors: Balucani, Clotilde1,2 (AUTHOR) clotilde_balucani@hotmail.com, Barlinn, Kristian1,3 (AUTHOR), Zivanovic, Zeljko1,4 (AUTHOR), Parnetti, Lucilla2 (AUTHOR), Silvestrini, Mauro5 (AUTHOR), Alexandrov, Andrei V.1 (AUTHOR)
Source: Stroke Research & Treatment. 2010, p1-8. 8p. 2 Charts.
Subject Terms: *HEALTH outcome assessment, *ISCHEMIA prevention, *MEDICAL experimentation on humans, *CEREBROVASCULAR disease, *PREVENTIVE medicine, *PLATELET aggregation inhibitors
Abstract: With majority of ischemic strokes attributable to atherothrombosis and many being predictable after transient ischemic attacks (TIA), the role of early secondary prevention with antiplatelet agents is under renewed investigation. Prior major clinical trials of various secondary stroke prevention regimens pointed to a greater efficacy of dual antiplatelet agents if initiated early from symptom onset. This paper examines data and rationale behind dual antiplatelet regimens across the completed clinical trials. The safety of dual antiplatelets approach is of concern, but it could be outweighed, at least in early management, by a greater reduction in recurrence of ischemic events since this risk is "front loaded" after minor stroke or TIA. Aspirin monotherapy, though considered standard of care, is compared to aspirin-extended release dipiridamole and its combination with clopidogrel in early-phase completed and efficacy-phase ongoing clinical trials. [ABSTRACT FROM AUTHOR]
Copyright of Stroke Research & Treatment is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
More Details
ISSN:20908105
DOI:10.4061/2010/427418
Published in:Stroke Research & Treatment
Language:English